
Company valuation, historical trends, and peer comparisons.
According to Theseus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 90.87M. This represents a change of -55.21% compared to the average of 202.88M of the last 4 quarters.
The mean historical Enterprise Value of Theseus Pharmaceuticals, Inc. over the last ten years is 311.03M. The current 90.87M Enterprise Value has changed -70.78% with respect to the historical average. Over the past ten years (40 quarters), THRX's Enterprise Value was at its highest in in the September 2021 quarter at 575.95M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.
Average
311.03M
Median
336.53M
Minimum
101.05M
Maximum
470.01M
Discovering the peaks and valleys of Theseus Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 470.01M
Minimum Annual Increase = -54.59%
Minimum Annual Enterprise Value = 101.05M
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 101.05M | -51.92% |
| 2021 | 210.18M | -54.59% |
| 2020 | 462.87M | -1.52% |
The current Enterprise Value of Theseus Pharmaceuticals, Inc. (THRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
258.04M
5-year avg
311.03M
10-year avg
311.03M
Theseus Pharmaceuticals, Inc.’s Enterprise Value is greater than Vaccitech plc (-18767734.00), greater than LENZ Therapeutics, Inc. (78.16M), less than LakeShore Biopharma Co., Ltd (404.70M), less than Spectrum Pharmaceuticals, Inc. (199.44M), less than F-star Therapeutics, Inc. (91.20M), greater than Alaunos Therapeutics, Inc. (6.07M), less than Zevra Therapeutics, Inc. (542.40M), greater than Selecta Biosciences, Inc. (-1403246.00), less than CARGO Therapeutics, Inc. Common Stock (181.23M), greater than aTyr Pharma, Inc. (10.29M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -18767734.00 | $192.73M | |
| 78.16M | $108.71M | |
| 404.70M | $25.84M | |
| 199.44M | $210.38M | |
| 91.20M | $156.51M | |
| 6.07M | $6.19M | |
| 542.40M | $663.32M | |
| -1403246.00 | $135.20M | |
| 181.23M | $216.19M | |
| 10.29M | $15.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theseus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theseus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Theseus Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX)?
What is the 3-year average Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX)?
What is the 5-year average Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX)?
How does the current Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX) compare to its historical average?